These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 5774189)

  • 21. Liver and plasma levels of descarboxyprothrombin (PIVKA II) in vitamin K deficiency in rats.
    Harauchi T; Takano K; Matsuura M; Yoshizaki T
    Jpn J Pharmacol; 1986 Apr; 40(4):491-9. PubMed ID: 3735800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin K antagonism of coumarin intoxication in the rat.
    Wallin R; Patrick SD; Ballard JO
    Thromb Haemost; 1986 Apr; 55(2):235-9. PubMed ID: 2424118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulant-resistant rats: possible control by the use of the chloro analog of vitamin K 1 .
    Suttie JW
    Science; 1973 May; 180(4087):741-3. PubMed ID: 4702571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin-induced changes in procoagulant and anticoagulant proteins.
    Stirling Y
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):361-73. PubMed ID: 8589201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
    Mosterd JJ; Thijssen HH
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of ticrynafen potentiation of coumarin anticoagulant action.
    Preusch PC; Suttie JW
    Biochem Pharmacol; 1983 Aug; 32(16):2393-8. PubMed ID: 6615542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC; Suttie JW
    J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMPARISON OF RAT LIVER RESPONSE TO COUMARIN ADMINISTERED IN VIVO VERSUS IN VITRO.
    POOL JG; BORCHGREVINK CF
    Am J Physiol; 1964 Jan; 206():229-38. PubMed ID: 14111447
    [No Abstract]   [Full Text] [Related]  

  • 29. Prothrombin synthesis in the rat.
    Nutr Rev; 1970 Oct; 28(10):271-5. PubMed ID: 4921474
    [No Abstract]   [Full Text] [Related]  

  • 30. Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety.
    Kamali F; Wood P; Ward A
    Ann Hematol; 2009 Feb; 88(2):141-9. PubMed ID: 18716776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of C-3 aliphatic coumarins as vitamin K antagonists.
    Montagut-Romans A; Boulven M; Jacolot M; Moebs-Sanchez S; Hascoët C; Hammed A; Besse S; Lemaire M; Benoit E; Lattard V; Popowycz F
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1598-1601. PubMed ID: 28254487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The vitamin K dependent, in vitro production of prothrombin.
    Shah DV; Suttie JW
    Biochem Biophys Res Commun; 1974 Oct; 60(4):1397-402. PubMed ID: 4425352
    [No Abstract]   [Full Text] [Related]  

  • 33. Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives.
    Kasperkiewicz K; Ponczek MB; Owczarek J; Guga P; Budzisz E
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32213944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanisms.
    Self TH; Oliphant CS; Reaves AB; Richardson AM; Sands CW
    Thromb Res; 2015 Jan; 135(1):5-8. PubMed ID: 25456000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism for potentiation of warfarin by phenylbutazone. Inhibition of vitamin K-dependent carboxylation and prothrombin synthesis by phenylbutazone in preparations from rat liver.
    Kelly LJ; Bell RG
    Biochem Pharmacol; 1981 Sep; 30(17):2443-9. PubMed ID: 21043243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of vitamin K and prothrombin synthesis: anticoagulants and the vitamin K--epoxide cycle.
    Bell RG
    Fed Proc; 1978 Oct; 37(12):2599-604. PubMed ID: 359368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.
    Wallin R
    Biochem J; 1986 Jun; 236(3):685-93. PubMed ID: 3098238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of clotting factors by a cell-free system from rat liver in response to the addition of vitamin K1 in vitro.
    Lowenthal J; Jaeger V
    Biochem Biophys Res Commun; 1977 Jan; 74(1):25-32. PubMed ID: 402132
    [No Abstract]   [Full Text] [Related]  

  • 39. The characterization of potent novel warfarin analogs.
    Kerr JS; Li HY; Wexler RS; Robinson AJ; Robinson CS; Boswell GA; Krauthauser C; Harlow PP
    Thromb Res; 1997 Oct; 88(2):127-36. PubMed ID: 9361366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
    Zivelin A; Rao LV; Rapaport SI
    J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.